MÖLNDAL, Sweden, Nov. 13, 2023 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has held a pre-submission meeting with the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results